Literature DB >> 17314270

Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.

Thuy-Vy Do1, Jay C Symowicz, David M Berman, Lance A Liotta, Emanuel F Petricoin, M Sharon Stack, David A Fishman.   

Abstract

Epithelial ovarian cancer (EOC) is asymptomatic at early stages and is often diagnosed late when tumor cells are highly metastatic. Lysophosphatidic acid (LPA) has been implicated in ovarian oncogenesis as levels of this lipid are elevated in patient ascites and plasma. Because the underlying mechanism governing LPA regulation of matrix metalloproteinase-2 (MMP-2) activation remains undefined, we investigated the relationship between LPA-induced changes in actin microfilament organization and MMP-2 enzymatic activity. We report that when cells were cultured at a high density, LPA mediated stress fiber and focal adhesion disassembly and significantly repressed RhoA activity in EOC cells. Inhibition of Rho-kinase/ROCK enhanced both LPA-stimulated loss of stress fibers and pro-MMP-2 activation. In contrast, expression of the constitutively active RhoA(G14V) mutant diminished LPA-induced pro-MMP-2 activation. LPA had no effects on membrane type 1-MMP or tissue inhibitor of metalloproteinase-2 expression, but up-regulated MMP-2 levels, contributing to the induction of MMP-2 activation. Interestingly, when cells were cultured at a low density, stress fibers were present after LPA stimulation, and ROCK activity was required for EOC cell migration. Collectively, these results were consistent with a model in which LPA stimulates the metastatic dissemination of EOC cells by initiating loss of adhesion and metalloproteinase activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17314270     DOI: 10.1158/1541-7786.MCR-06-0319

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  15 in total

1.  Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis.

Authors:  Sue-Chin Lee; Yuko Fujiwara; Jianxiong Liu; Junming Yue; Yoshibumi Shimizu; Derek D Norman; Yaohong Wang; Ryoko Tsukahara; Erzsebet Szabo; Renukadevi Patil; Souvik Banerjee; Duane D Miller; Louisa Balazs; Manik C Ghosh; Christopher M Waters; Tamas Oravecz; Gabor J Tigyi
Journal:  Mol Cancer Res       Date:  2014-08-26       Impact factor: 5.852

Review 2.  Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.

Authors:  Mu-En Lin; Deron R Herr; Jerold Chun
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-04       Impact factor: 3.072

3.  Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.

Authors:  Rebecca J Burkhalter; Suzanne D Westfall; Yueying Liu; M Sharon Stack
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

4.  Combination therapy of an inhibitor of group VIA phospholipase A2 with paclitaxel is highly effective in blocking ovarian cancer development.

Authors:  Hui Li; Zhenwen Zhao; Caryl Antalis; Zhanzhong Zhao; Robert Emerson; Gang Wei; Sheng Zhang; Zhong-Yin Zhang; Yan Xu
Journal:  Am J Pathol       Date:  2011-05-17       Impact factor: 4.307

Review 5.  Activated epidermal growth factor receptor in ovarian cancer.

Authors:  Laurie G Hudson; Reema Zeineldin; Melina Silberberg; M Sharon Stack
Journal:  Cancer Treat Res       Date:  2009

6.  Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.

Authors:  T-V Do; F Xiao; L E Bickel; A J Klein-Szanto; H B Pathak; X Hua; C Howe; S W O'Brien; M Maglaty; J A Ecsedy; S Litwin; E A Golemis; R J Schilder; A K Godwin; D C Connolly
Journal:  Oncogene       Date:  2013-01-21       Impact factor: 9.867

7.  Expressions of lysophosphatidic acid receptors in the development of human ovarian carcinoma.

Authors:  Jinge Si; Yuanyuan Su; Yifeng Wang; You-Liang Yan; Ya-Ling Tang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.

Authors:  C Mahanivong; H M Chen; S W Yee; Z K Pan; Z Dong; S Huang
Journal:  Oncogene       Date:  2007-08-27       Impact factor: 9.867

9.  S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.

Authors:  Kathleen M Devine; Yoel Smicun; Joanie Mayer Hope; David A Fishman
Journal:  Gynecol Oncol       Date:  2008-05-29       Impact factor: 5.482

Review 10.  Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression.

Authors:  Laurie G Hudson; Reema Zeineldin; M Sharon Stack
Journal:  Clin Exp Metastasis       Date:  2008-04-09       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.